Literature DB >> 35543878

Radical cystectomy and chemotherapy on plasmacytoid variant bladder urothelial carcinoma.

Yuxuan Song1, Caipeng Qin1, Yiqing Du2, Tao Xu3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35543878     DOI： 10.1007/s00345-022-04033-z

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   3.661


× No keyword cloud information.
  5 in total

1.  The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.

Authors:  Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene O Siefker-Radtke; Randall E Millikan; Colin P N Dinney
Journal:  Clin Cancer Res       Date:  2010-07-22       Impact factor: 12.531

2.  Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.

Authors:  Amit Khanal; Nibash Budhathoki; Vijay Pal Singh; Binay K Shah
Journal:  Anticancer Res       Date:  2017-04       Impact factor: 2.480

3.  Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients.

Authors:  Gabriele Sorce; Rocco Simone Flammia; Benedikt Hoeh; Francesco Chierigo; Benedikt Horlemann; Christoph Würnschimmel; Zhe Tian; Markus Graefen; Carlo Terrone; Michele Gallucci; Felix K H Chun; Fred Saad; Shahrokh F Shariat; Francesco Montorsi; Alberto Briganti; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2022-01-27       Impact factor: 3.661

4.  The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis.

Authors:  Jiafeng Shou; Qi Zhang; Dahong Zhang
Journal:  World J Urol       Date:  2021-05-24       Impact factor: 4.226

5.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.